TerminatedNot Applicable

Influenza Vaccine in Preventing Flu in Patients Who Have Undergone Stem Cell Transplant and in Healthy Volunteers

Stopped: Very low enrollment and follow-up, cannot meet study objectives

United States9 participantsStarted 2008-11

Plain-language summary

RATIONALE: The influenza vaccine may help prevent flu in patients who have undergone stem cell transplant. PURPOSE: This clinical trial is studying how well the influenza vaccine works in preventing flu in patients who have undergone stem cell transplant and in healthy volunteers.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

DISEASE CHARACTERISTICS: * Meets 1 of the following: * Patient at City of Hope or Kaiser hospital who underwent prior autologous or allogeneic matched-related hematopoietic stem cell transplantation (HSCT) or matched-unrelated HSCT for treatment of hematological malignancies, including aplastic anemia or myelodysplastic syndromes * Must agree to return to City of Hope for screening every 2-4 weeks during the flu season * 100-365 days post-transplant * Any prior therapy allowed * Employee volunteer from the City of Hope who agrees to have a nasopharyngeal wash performed at General Clinical Research Center every 2 weeks during the flu season * Must be eligible (per physicians instructions) and vaccinated during the 2008-2009 or 2009-2010 flu season PATIENT CHARACTERISTICS: * Life expectancy \> 9 months PRIOR CONCURRENT THERAPY: * See Disease Characteristics

What they're measuring

Incidence of influenza infection in patients and healthy volunteers

Trial details

NCT IDNCT00952185

SponsorCity of Hope Medical Center

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2010-06

View on ClinicalTrials.gov More Brain and Central Nervous System Tumors trials